W Tao

W Tao's publicly available research record is very limited, with the clearest example being a 2022 study in Cell Metabolism on the CD24-Siglec axis, a molecular pathway that helps regulate immune responses and may protect against chronic low-grade inflammation linked to metabolic disorders. The listed topic areas suggest an interest in immune cell signaling, protein regulation, and molecular tools used to study these processes, but there is not enough consistent publication data to describe a well-established research program.

The available data show sparse and irregular output over the last decade, with no publications recorded in most years and small upticks in 2022 and a projected 2026 entry, making it difficult to characterize a steady trend.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026